Oragenics Inc. Common Stock (OGEN)
0.2960
+0.0119 (4.19%)
Oragenics Inc is a biotechnology company focused on the development of innovative solutions for infectious diseases and oral health
The company is primarily engaged in creating novel antibiotics and therapeutics, particularly against multi-drug resistant pathogens, as well as products aimed at enhancing oral health through advanced microbial therapies. Oragenics leverages its proprietary technologies and research capabilities to address significant medical needs, with a mission to improve patient outcomes and combat rising antibiotic resistance through targeted and effective treatment options.
Frequently Asked Questions
Is Oragenics Inc. Common Stock publicly traded?
Yes, Oragenics Inc. Common Stock is publicly traded.
What exchange does Oragenics Inc. Common Stock trade on?
Oragenics Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Oragenics Inc. Common Stock?
The ticker symbol for Oragenics Inc. Common Stock is OGEN on the New York Stock Exchange
What is the current price of Oragenics Inc. Common Stock?
The current price of Oragenics Inc. Common Stock is 0.2960
When was Oragenics Inc. Common Stock last traded?
The last trade of Oragenics Inc. Common Stock was at 8:00 pm EST on February 5th, 2025
What is the market capitalization of Oragenics Inc. Common Stock?
The market capitalization of Oragenics Inc. Common Stock is 3.61M
How many shares of Oragenics Inc. Common Stock are outstanding?
Oragenics Inc. Common Stock has 12.21M shares outstanding.